No effect of Gilead's remdesivir on COVID-19 patients: WHO

ZURICH|GENEVA: A World Health Organization (WHO) trial that concluded Gilead Sciences Inc. remdesivir did not significantly help COVID-19 patients is reliable, a scientist who evaluated it said on Friday, as the U.S. company criticized its methodology.